Publication

Article

Applied Clinical Trials

Applied Clinical Trials-10-01-2021
Volume30
Issue 10

Applied Clinical Trials October 2021 Issue (PDF)

Click the title above for a link to open the Applied Clinical Trials October 2021 issue in an interactive PDF format.

Click cover to access PDF

Download Issue PDF
Articles in this issue
Interoperability Cracked as Patients Collect Health Records from Hospitals
Interoperability Cracked as Patients Collect Health Records from Hospitals
Sites Still Necessary for Decentralized Trials
Sites Still Necessary for Decentralized Trials
The Evolution of Site Selection
Utilization of EMS Data in Site Selection
Utilization of EMS Data in Site Selection
“Warm and Ready” Clinical Trial Sites
“Warm and Ready” Clinical Trial Sites
Applied Clinical Trials October 2021 Issue (PDF)
Applied Clinical Trials October 2021 Issue (PDF)

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!
Related Videos
Related Content
Epkinly Demonstrates Encouraging Efficacy in Phase II Trial for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
September 4th 2025

Epkinly Demonstrates Encouraging Efficacy in Phase II Trial for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Don Tracy, Associate Editor
ACT Brief Episode 6: Supreme Court Ruling, VK2735 Obesity Trial, and Padcev-Keytruda Survival Gains
September 4th 2025

ACT Brief Episode 6: Supreme Court Ruling, VK2735 Obesity Trial, and Padcev-Keytruda Survival Gains

Andy Studna, Senior Editor
Leqvio Shows Clinically Meaningful LDL-C Goal Attainment in Patients with Hypercholesterolemia in Phase IV Trial
September 4th 2025

Leqvio Shows Clinically Meaningful LDL-C Goal Attainment in Patients with Hypercholesterolemia in Phase IV Trial

Don Tracy, Associate Editor
ACT Brief Episode 5: How Digital Twins and AI Are Reshaping Clinical Trials
September 4th 2025

ACT Brief Episode 5: How Digital Twins and AI Are Reshaping Clinical Trials

Andy Studna, Senior Editor
Merck’s Oral PCSK9 Inhibitor Demonstrates Efficacy in Hypercholesterolemia
September 4th 2025

Merck’s Oral PCSK9 Inhibitor Demonstrates Efficacy in Hypercholesterolemia

Don Tracy, Associate Editor
AstraZeneca’s Baxdrostat Shows Promise in Phase III Trial for Hard-to-Control Hypertension
September 4th 2025

AstraZeneca’s Baxdrostat Shows Promise in Phase III Trial for Hard-to-Control Hypertension

Don Tracy, Associate Editor
© 2025 MJH Life Sciences

All rights reserved.